Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0024141 (
systemic lupus erythematosus
)
44,322
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Content of antibodies to neutrophil cytoplasma--
myeloperoxidase
(
MPO
)--and proteinase-3 (PR-3) was measured in the sera of 65 patients with
SLE
and 20 donors. Antibodies to
MPO
(a-MPO) and proteinase-3 (a-PR-3) significantly outnumbered those of the control. The number of a-
MPO
appeared elevated in 13, lowered in 7, moderate in 6 cases and directly correlated with anemia, pulmonary lesions, a-PR-3 level, inversely correlated with cerebrovasculitis and polyneuritis. The number of a-PR-3 was elevated in 14 cases (10 low titers and 4 moderate titers). High levels of both a-PR-3 and a-
MPO
were recorded in 8 sera. The content of a-PR-3 correlated directly with age of
SLE
onset but inversely with leukocyte count. Neither course of the disease nor inflammation activity were related to level of neutrophil antibodies. Factor analysis has identified groups of elements influencing the value of a-
MPO
and a-PR-3.
...
PMID:[Clinical significance of myeloperoxydase and proteinase 2 antibodies in patients with systemic lupus erythematosus]. 1059 20
A 46-year-old female was admitted to our hospital due to general fatigue, systemic edema and dyspnea with history of systemic sclerosis (SSc). The patient was diagnosed as mixed connective tissue disease (MCTD) based on Raynaud phenomenon, a high anti-RNP antibody level and clinical symptoms and laboratory findings suggesting SSc, dermatomyositis (DM) and
systemic lupus erythematosus
(
SLE
). After the admission, both alveolar hemorrhage and a rapidly progressive glomerulonephritis (RPGN) also developed and laboratory findings showed a positive remark of myeloperoxydase-antineutrophil cytoplasmic antibody (MPO-ANCA) and anti-glomerular basement membrane (GBM) antibody. She was therefore re-diagnosed as microscopic polyarteritis nodosa (microscopic PAN) combined with MCTD and treatment with high dose prednisolone and steroid pulse therapy dramatically improved general conditions and lung symptoms, but maintenance dialysis was persistent because of irreversible renal failure. However, 3 months after the admission, she died of acute exacerbation of interstitial pneumonitis that was unresponsive to steroid pulse therapy. Autopsy revealed interstitial pneumonitis with alveolar hemorrhage and crescentic glomerulonephritis (CrGN), in which immunofluorescent microscopy showed no deposition in agreement with pauciimmune type. The histological findings supported the diagnosis; primary microscopic PAN combined with MCTD, which is a quite rare case, to our knowledge. Furthermore, co-existence of
MPO
ANCA and anti-GBM antibody, clinical and histological findings of the case also lead us to reconsider the relevance of these antibodies to pathogenesis and/or categories of microscopic PAN and Goodpasture's syndrome.
...
PMID:[A case of mixed connective tissue disease with microscopic polyarteritis nodosa associated with perinuclear-antineutrophil cytoplasmic antibody and anti-glomerular basement membrane]. 1061 88
To elucidate the prevalence and clinical implications of antineutrophil cytoplasmic antibody (ANCA) in lupus nephritis (LN), we examined ANCA by indirect immunofluorescence and by ELISA against antilactoferrin (anti-LF) and antimyeloperoxidase (anti-MPO) antibody. To discriminate perinuclear ANCA (pANCA) with antinuclear antibody (ANA), all the ANCA-positive sera were tested again after incubating patients' sera with single-stranded (SS) and double-stranded (ds) DNA. These results were compared with clinicopathologic manifestations and clinical courses of LN. ANCA was positive in 19 (37.3%) of 51 LN patients. Among these LN patients, 3 had cytoplasmic ANCA (cANCA) and 16 had pANCA. ANCA was not found in 8
SLE
patients without nephritis and 30 normal controls. The presence of ANCA, particularly pANCA, was associated with the presence of nephritis (18/51 cases vs. 0/8 cases, p < 0.05), especially with diffuse proliferative lupus nephritis, WHO class IV (17/18 cases vs. 21/31 cases, p < 0.05) as well as the presence of anti-dsDNA antibody (17/19 cases vs. 18/30 cases, p < 0.05). Patients with ANCA frequently had deterioration of renal function (3/16 vs. 0/26 cases). Anti-LF antibody was positive in 13 patients. Among those, 12 patients had nephritis. Five patients with anti-LF antibody did not have ANCA, but 7 had pANCA, and 1 had cANCA. Patients with anti-LF antibody had lower initial creatinine levels than those without it [serum creatinine (mg/dl): 0.78 (0.6-1.0) vs. 1.43 (0.5-5.0), p < 0.05]. Anti-
MPO
antibody was positive in only 1 patient, suggesting that
MPO
is a rare antigen for ANCA in LN.
...
PMID:Clinical implications of antineutrophil cytoplasmic antibody test in lupus nephritis. 1064 70
Several rodent models have been proposed for various forms of systemic vasculitis. The MRL-lpr mouse has been studied extensively as a model for
systemic lupus erythematosus
. Backcross experiments in combination with genetic linkage studies have firmly established that the phenotype of autoimmune disease is dependent on the combination of various background genes. It has also become apparent that environmental factors, particularly infections, modulate the disease phenotype. Specific interventions, such as the treatment of Brown Norway rats with agents resulting in polyclonal B cell stimulation or immunization with human
myeloperoxidase
and subsequent localized perfusion with neutrophil lysosomal extract and H2O2, have provided substantial insights into the cellular and molecular mechanisms leading to the development of vasculitis and glomerulonephritis. Even though the existing models may not exactly mirror any specific human disease, they offer reproducible, highly controlled conditions to answer specific questions about pathogenesis and novel therapeutic approaches.
...
PMID:Are animal models of vasculitis suitable tools? 1064 49
To investigate the prevalence and clinical relevance of immunoglobulin (Ig) isotypes of antimyeloperoxidase (
MPO
) and antilactoferrin (LF) antibodies in collagen diseases, enzyme-linked immunosorbent assay was employed to detect the Ig isotypes of both antibodies. The purified proteins of
MPO
and LF were used as two major representative antigens for anti-neutrophil cytoplasmic antibodies (ANCA) with a perinuclear staining pattern by an indirect immunofluorescent technique. We examined 131 serum samples from 79 patients with rheumatoid arthritis (RA), 32 with
systemic lupus erythematosus
(
SLE
), 14 with progressive systemic sclerosis (PSS), 6 with polymyositis/dermatomyositis (PM/DM), and 5 with idiopathic crescentic glomerulonephritis who served as positive controls and 36 healthy subjects who served as controls. A limited number of patients with RA (4-10%),
SLE
(6-9%), and PSS (7-14%) but not PM/DM showed positive IgG or IgA anti-
MPO
antibody (
MPO
-ANCA) but not IgM
MPO
-ANCA. However, 10-20% of RA, 40-60% of
SLE
, 20-36% of PSS but none of the PM/DM patients showed positive IgG, IgA, or IgM anti-LF antibody (LF-ANCA).
MPO
- and LF-ANCA positivity in RA patients was correlated with markers of disease activity such as the erythrocyte sedimentation rate, C-reactive protein, and serum Ig levels. IgG LF-ANCA but not
MPO
-ANCA positivity in
SLE
patients also was correlated with the disease activity index but not with clinical features. Neither
MPO
- nor LF-ANCA positivity in PSS patients was correlated with any clinical features. Overall, both
MPO
- and LF-ANCA were found mainly in RA,
SLE
, and PSS patients but not in PM/DM patients. The Ig isotypes of
MPO
- and LF-ANCA frequently belonged to both IgG and IgA and rarely to the IgM class. Both
MPO
- and LF-ANCA positivity reflected disease activity in RA and
SLE
rather than specific organ involvement.
...
PMID:Immunoglobulin isotypes of anti-myeloperoxidase and anti-lactoferrin antibodies in patients with collagen diseases. 1093 15
Renal diseases of mixed connective tissue disease (MCTD) are not unusual. Although most of them are
SLE
-like renal impairment with immune complex deposits, systemic sclerosis- (SSc) like renal impairments with intimal thickening of interlobular arteries or arterioles are also encountered. Several cases of SSc complicated with
MPO
-ANCA-related necrotizing glomerulonephritis (nGN) are reported. Here we report a case which developed
MPO
-ANCA-related nGN 16 years after the diagnosis of MCTD. She exhibited pauci-immune focal nGN and significantly high titer of
MPO
-ANCA. She was successfully treated with prednisolone and cyclophosphamide. We believe this is the first case in which
MPO
-ANCA-related nGN was demonstrated in a patient with MCTD.
...
PMID:A case of mixed connective tissue disease (MCTD) complicated with MPO-ANCA-related necrotizing glomerulonephritis. 1096 96
Anti-
myeloperoxidase
antibodies (anti-MPO) are a major type of anti-neutrophil cytoplasmic antibody (ANCA). While evaluating anti-
MPO
monoclonal antibodies from SCG/Kj mice, we observed several hybridomas that appeared to react with both
MPO
and DNA. Sera from some patients with
systemic lupus erythematosus
(
SLE
) also react with
MPO
and DNA. We hypothesized that the
MPO
binding activity is a false-positive result due to the binding of DNA, contained within the antigen binding site of anti-DNA antibodies, to the cationic
MPO
. Antibodies from tissue culture supernatants from 'dual reactive' hybridomas were purified under high-salt conditions (3 M NaCl) to remove any antigen bound to antibody. The
MPO
and DNA binding activity were measured by ELISA. The
MPO
binding activity was completely abrogated while the DNA binding activity remained. The
MPO
binding activity was restored, in a dose-dependent manner, by the addition of increasing amount of calf-thymus DNA (CT-DNA) to the purified antibody. Sera from six patients with
SLE
that reacted with both
MPO
and DNA were treated with DNase and showed a decrease in
MPO
binding activity compared with untreated samples.
MPO
binding activity was observed when CT-DNA was added to sera from
SLE
patients that initially reacted with DNA but not with
MPO
. These results suggest that the DNA contained within the antigen binding site of anti-DNA antibodies could bind to the highly cationic
MPO
used as substrate antigen in immunoassays, resulting in a false-positive test.
...
PMID:False-positive myeloperoxidase binding activity due to DNA/anti-DNA antibody complexes: a source for analytical error in serologic evaluation of anti-neutrophil cytoplasmic autoantibodies. 1097 23
We described four patients who had clinical diagnosis of erythema infectiosum and presented with skin rash, polyarthralgia, polyarthritis, and mild fever. Anti-parvovirus B19 IgM and IgG antibodies were found in all four patients and parvovirus B19 DNA was detected in three of the four patients by polymerase chain reaction (PCR) in sera using standard methods. Anticardiolipin antibody (aCL) was positive in three of the four patients included three with anti-beta2 glycoprotein I (beta2GPI). The immunoglobulin isotype of aCL was found to be IgM. Anti-neutrophil cytoplasmic antibody (ANCA) included three p-ANCA and one c-ANCA was detected in all four patients by indirect immunofluoresence (IIF). Both anti-proteinase 3 (PR3) and anti-
myeloperoxidase
(
MPO
) antibodies were found in two patients whom had polyarthritis for more than 6 months. These data indicate parvovirus B19 may be linked to the induction of an autoimmune response.
Lupus
2000
PMID:Parvovirus B19 infection associated with the production of anti-neutrophil cytoplasmic antibody (ANCA) and anticardiolipin antibody (aCL). 1103 24
Antibodies to human
myeloperoxidase
and cathepsin G have been detected in the serum of some patients with
systemic lupus erythematosus
. Therefore, the presence of antibodies to human
myeloperoxidase
and cathepsin G was examined in glomerular immune deposits. Glomerular basement membrane fragments were prepared from renal tissues obtained at autopsy from 19 patients with
systemic lupus erythematosus
. IgG was extracted from the glomerular basement membrane fragments and tested with sensitive immunoassays for antibodies to
myeloperoxidase
and cathepsin G. Antibodies to cathepsin G were not detected in the extracts but antibodies to human
myeloperoxidase
were found in extracts of one specimen. In the extract with 6M guanidine hydrochloride these antibodies were enriched 103-fold, compared to the initial supernatant of glomeruli, which served as a serum surrogate. The recovered antibodies to
myeloperoxidase
accounted for 12% of the recovered IgG. These findings add autoantibodies to human
myeloperoxidase
to the list of antibodies that have been shown to be present in glomerular immune deposits of patients with
lupus
glomerulonephritis.
Lupus
2000
PMID:Antibodies to human myeloperoxidase in glomerular immune deposits of systemic lupus erythematosus. 1103 36
The drug-metabolizing capacity of the liver is well known but cannot account for most idiosyncratic adverse drug reactions. Of the extrahepatic sources of reactive drug metabolites, the neutrophil has received the most attention because of its vast numbers and robust oxidizing machinery. Many drugs associated with autoimmunity are susceptible to oxidative transformation by the enzymatic action of
myeloperoxidase
, a protein released into the extracellular environment when neutrophils are activated. Production of the resulting drug metabolites within lymphoid organs maximizes their immune-perturbing effects. Mechanisms proposed for the initiation of drug-induced blood dyscrasias, hypersensitivity reactions, or
lupus
-like symptoms center around three views: (1) presentation of the implicated compound in the major histocompatibility complex of antigen-presenting cells via direct binding or after processing as a hapten bound to self-macromolecules, (2) direct cytotoxicity, or (3) interference in the development of T-cell tolerance in the thymus. How participation of reactive drug metabolites in these processes might lead to symptomatic disease is discussed.
...
PMID:Phagocyte-mediated oxidation in idiosyncratic adverse drug reactions. 1113 24
<< Previous
1
2
3
4
5
6
7
8
9
10
Next >>